Our proteomics results also indicate there are molecular changes in astrocytes in PSP, as we observe changes in levels of GFAP, YKL40/CHI3L1 and ICAM1 and several neuro-immune pathways. This evidence concerns the gene GFAP and supranuclear palsy, progressive, 1.